Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/32854
Title: Interaction of Purinergic P2X4 and P2X7 Receptor Subunits
Author(s): Schneider, Markus
Prudic, Kirsten
Klapperstück, Manuela
Braam, Ursula
Müller, Christa
Schmalzing, Günther
Markwardt, Fritz
Issue Date: 2017-11-22
Type: Article
Language: English
Publisher: Universitäts- und Landesbibliothek Sachsen-Anhalt
Subjects: P2X4
P2X7
voltage clamp
fluorescence
FRET
interaction
subunit
Abstract: P2X4 and P2X7 are members of the P2X receptor family, comprising seven isoforms (P2X1–P2X7) that form homo- and heterotrimeric non-specific cation channels gated by extracellular ATP. P2X4 and P2X7 are widely coexpressed, particularly in secretory epithelial cells and immune and inflammatory cells, and regulate inflammation and nociception. Although functional heteromerization has been established for P2X2 and P2X3 subunits expressed in sensory neurons, there are contradictory reports regarding a functional interaction between P2X4 and P2X7 subunits. To resolve this issue, we coexpressed P2X4 and P2X7 receptor subunits labeled with green (EGFP) and red (TagRFP) fluorescent proteins in Xenopus laevis oocytes and investigated a putative physical interaction between the fusion proteins by Förster resonance energy transfer (FRET). Coexpression of P2X4 and P2X7 subunits with EGFP and TagRFP located in the extracellular receptor domains led to significant FRET signals. Significant FRET signals were also measured between C-terminally fluorophore-labeled full-length P2X41-384 and C-terminally truncated fluorescent P2X71-408 subunits. We furthermore used the two-electrode voltage clamp technique to investigate whether human P2X4 and P2X7 receptors (hP2X4, hP2X7) functionally interact at the level of ATP-induced whole-cell currents. Concentration–response curves and effects of ivermectin (P2X4-potentiating drug) or BzATP (P2X7-specific agonist) were consistent with a model in which coexpressed hP2X4 and hP2X7 do not interact. Similarly, the effect of adding specific inhibitors of P2X4 (PSB-15417) or P2X7 (oATP, A438079) could be explained by a model in which only homomers exist, and that these are blocked by the respective antagonist. In conclusion, we show that P2X4 and P2X7 subunits can form heterotrimeric P2X4/P2X7 receptors. However, unlike observations for P2X2 and P2X3, coexpression of P2X4 and P2X7 subunits does not result in a novel electrophysiologically discriminable P2X receptor phenotype.
URI: https://opendata.uni-halle.de//handle/1981185920/33045
https://lhhal.gbv.de/DB=10/XMLPRS=N/PPN?PPN=1047296373
http://dx.doi.org/10.25673/32854
Open Access: Open access publication
License: (CC BY 4.0) Creative Commons Attribution 4.0(CC BY 4.0) Creative Commons Attribution 4.0
Sponsor/Funder: DFG Ma1581/15– 3
DFG Schm536/9–3
Journal Title: Frontiers in Pharmacology
Volume: 8
Original Publication: 10.3389/fphar.2017.00860
Page Start: 860
Appears in Collections:Medizinische Fakultät MLU

Files in This Item:
File Description SizeFormat 
fphar-08-00860_mlu.pdf6.41 MBAdobe PDFThumbnail
View/Open